UK and European research collaborations in cancer research have received a vote of confidence by three major cancer charities, with an announcement today of approximately £30 million into six international projects.
Cancer Research UK is partnering with two of Europe’s leading cancer research charities, AIRC (Associazione Italiana per la Ricerca sul Cancro) and FC AECC (Asociación Española Contra el Cáncer), to invest in six international collaborations, which are aimed at accelerating progress in translational research.
Scientists in the 5-year funded Accelerator Awards* projects will investigate the potential of immunotherapies in treating liver cancer; develop manufacturing methods for CAR-T cell production; track cancer cell evolution; investigate drug resistance in blood cancers; devise a blood test for advanced prostate cancer and find new routes for personalising blood cancer treatment.
As the UK and EU work to form a new relationship after Brexit, the awards are an example of how funding organisations are seeking to continue to collaborate post-Brexit to drive research forward.
Dr Iain Foulkes, executive director of research and innovation at Cancer Research UK, said: “No single organisation or country is going to beat cancer on its own. Research must be prioritised as the UK builds a new relationship with
Article originally posted at